SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model
Physiological Reports · 2023
DOI: 10.14814/phy2.15858 ↗At a glance
Journal article in Physiological Reports, 2023. Written by Manal Moustafa Mahmoud and 6 co-authors. Institution: Department of Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt. Major MEDLINE topics: Metformin, Polycystic Ovary Syndrome, Sodium-Glucose Transporter 2 Inhibitors, Insulin Resistance. Cited 14 times so far (Crossref); 97 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Polycystic ovary syndrome (PCOS) is a common endocrine, reproductive, and metabolic disorder affecting females. The management of PCOS is challenging and current interventions are not enough to deal with all consequences of this syndrome. We explored the beneficial effect of combined sodium glucose co transporter‐2 inhibitor (SGLT‐2i); (empagliflozin) and metformin on hormonal and metabolic parameters in an animal model of PCOS and insulin resistance (IR). Forty adult female Wistar rats divided into five groups: control, PCOS‐IR, PCOS‐IR treated with metformin, PCOS‐IR treated with empagliflozin, and PCOS‐IR treated with combined metformin and empagliflozin. Single modality treatment with metformin or empagliflozin yielded significant improvement in body mass index, insulin resistance, lipid profile, sex hormones, inflammatory markers, and ovarian cystic follicles. Combined metformin with empagliflozin expressed further significant improvement in sex hormones, inflammatory markers with disappearance of ovarian cystic follicles. The superior significant improvement with combined treatment over the single modality was in line with significant improvement in the ovarian AMPKα‐SIRT1 expression.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt.
- Department of Biochemistry Faculty of Medicine, Cairo University, Cairo, Egypt.
- Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
- Department of Physiology, School of Medicine, New Giza University, Cairo, Egypt.
- Department of Histology, Faculty of Medicine, Cairo University, Cairo, Egypt.
- Department of Histology, Armed Forces College of Medicine, Cairo, Egypt.
ORCID profiles: Manal Moustafa Mahmoud, Laila Ahmed Rashed, Somia Abdulatif Soliman, Samaa Samir Kamar, Rania El Sayed Hussien
Cite
APA
Mahmoud, M. M., Rashed, L. A., Soliman, S. A., Sayed, S. M., Kamel, O., Kamar, S. S., & Hussien, R. E. S. (2023). SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model. Physiological Reports. https://doi.org/10.14814/phy2.15858
Vancouver
Mahmoud MM, Rashed LA, Soliman SA, Sayed SM, Kamel O, Kamar SS, et al. SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model. Physiological Reports. 2023. doi:10.14814/phy2.15858
BibTeX
@article{Mahmoud2023,
author = {Mahmoud, Manal Moustafa and Rashed, Laila Ahmed and Soliman, Somia Abdulatif and Sayed, Safaa Mostafa and Kamel, Omneya and Kamar, Samaa Samir and Hussien, Rania El Sayed},
title = {SGLT ‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model},
journal = {Physiological Reports},
year = {2023},
doi = {10.14814/phy2.15858}
}
EUVIMED